FOXO Technologies Inc.

FOXO Technologies Inc. is a healthcare services and technology company operating four synergistic divisions: a rural hospital division, a mental and behavioral health division, an information, data and biospecimen sourcing division, and an epigenetics diagnostics and interpretation division. The company's mission is to build healthier communities by offering a diverse and adaptable range of healthcare services and solutions. FOXO Technologies Inc., formerly Delwinds Insurance Acquisition Corp., was originally formed in April 2020. Through acquisitions, the company offers behavioral health services, including substance use disorder treatment, and operates a critical access designated hospital in Oneida, Tennessee. It also serves as an information, data, and biospecimen sourcing provider for the biotechnology, clinical research, and pharmaceutical research industries. Additionally, FOXO is commercializing epigenetic biomarker technology for scientific research and next-generation business initiatives. The company manages its business through three reportable segments: Healthcare, Life Science Services, and Labs. Myrtle Recovery Centers, Inc. (acquired June 14, 2024), Rennova Community Health, Inc., and its subsidiary Scott County Community Health, Inc. (acquired September 10, 2024) operate under the Healthcare segment. Vector BioSource Inc. (acquired September 19, 2025) operates under the Life Science Services segment. The Labs segment was formed by combining the previously separate Labs and Life segments during the second quarter of 2024, following the acquisition of Myrtle in June 2024.